OpenAlex
PricingAboutJobs
Log inGet started
Work

Combining chemotherapy with PD-1 blockade in NSCLC

HTML

Year: 2018
Type: review
Source: Pharmacology & Therapeutics
DOI: 10.1016/j.pharmthera.2018.01.003
Authors: Matthen Mathew, Thomas Enzler, Catherine A. Shu, Naiyer A. Rizvi
Institution: Columbia University Irving Medical Center
Language: English

Topic: Cancer Immunotherapy and Biomarkers
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Keywords: non-small cell lung cancer, anti-PD-1 therapy, immune checkpoint inhibitors, PD-L1, combination chemotherapy, immunogenic cell death, immunosuppressive tumor microenvironment, antitumor immunity, T cell cytotoxicity, first-line therapy, combination therapy
SDG: Good health and well-being

Open Access status: closed

Funder: Amgen
OpenAlex ID: W2792286951
FWCI: 1.565
Cites: 63
Cited by: 158
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security